NDLI: Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

Please wait, while we are loading the content...

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

Content Provider	Scilit
Author	Paragliola, Rosa Maria Prete, Alessandro Papi, Giampaolo Torino, Francesco Corsello, Andrea Pontecorvi, Alfredo Corsello, Salvatore Maria
Copyright Year	2016
Description	Clinical utility of lanreotide AutogelÂ® in gastroenteropancreatic neuroendocrine tumors Rosa Maria Paragliola,1 Alessandro Prete,1 Giampaolo Papi,1 Francesco Torino,2 Andrea Corsello,3 Alfredo Pontecorvi,1 Salvatore Maria Corsello1 1Department of Medicine, Unit of Endocrinology, UniversitÃ Cattolica del Sacro Cuore, 2Department of Systems Medicine, Tor Vergata University, Rome, 3Department of General Medicine and Endocrine Tumor Unit, San Raffaele Scientific Institute, Milan, Italy Somatostatin analogs (SSAs), which were initially used to control hormonal syndromes associated with neuroendocrine neoplasms (NENs), have been successfully proposed as antiproliferative agents, able to control tumor growth in patients affected by gastroenteropancreatic (GEP)-NENs. The development of long-acting formulations of SSAs which require only weekly or monthly injections can improve patient compliance. In particular, lanreotide (LAN) AutogelÂ®, which is a viscous aqueous formulation supplied in ready-to-use prefilled syringes, can be administered every 28â
Related Links	https://core.ac.uk/download/pdf/80178058.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087808/pdf https://www.dovepress.com/getfile.php?fileID=33151
Ending Page	3470
Page Count	12
Starting Page	3459
e-ISSN	11778881
DOI	10.2147/dddt.s76732
Journal	Drug design, development and therapy
Volume Number	10
Language	English
Publisher	Informa UK Limited
Publisher Date	2016-10-01
Access Restriction	Open
Subject Keyword	Journal: Drug Design, Development and Therapy Endocrinology and Metabolism Lanreotide Autogel Gastroenteropancreatic Neuroendocrine Tumors Gastroentero-pancreatic Neuroendocrine Neoplasms Somatostatin Analogs
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in